21:53 , Dec 1, 2017 |  BC Week In Review  |  Company News

AbCheck, Molecular Templates partner to identify oncology antibodies

Affimed N.V. (NASDAQ:AFMD) subsidiary AbCheck s.r.o. (Plzen, Czech Republic) and Molecular Templates Inc. (NASDAQ:MTEM) partnered to discover antibodies to treat cancer. AbCheck will use its AbSieve discovery technology to identify antibodies against targets selected by...
07:00 , Aug 3, 2015 |  BC Week In Review  |  Company News

Pierre Fabre Group, Affimed deal

Affimed’s AbCheck s.r.o. subsidiary and Pierre Fabre expanded their 2014 deal granting Pierre Fabre rights to develop and commercialize antibodies discovered by AbCheck using AbSeive technology against undisclosed targets from Pierre Fabre (see BioCentury,...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Company News

AbCheck, Pierre Fabre deal

AbCheck will use its AbSieve discovery platform to discover antibodies against undisclosed targets from Pierre Fabre. AbCheck will receive discovery fees and is eligible for milestones. Pierre Fabre will have rights to the antibodies. AbSieve...
08:00 , Feb 25, 2013 |  BC Week In Review  |  Company News

AbCheck, Daiichi Sankyo deal

AbCheck will use its AbSieve phage and yeast display technologies to discover antibodies against an undisclosed number of cancer targets from Daiichi's U3 Pharma GmbH affiliate. U3 will have rights to any antibodies developed under...
07:00 , Oct 11, 2010 |  BC Week In Review  |  Company News

AbCheck, Eli Lilly deal

AbCheck will use its three antibody libraries to discover antibodies against targets selected by Eli Lilly, which will have rights to any antibodies discovered. AbCheck will receive discovery fees and is eligible for milestones. Further...
23:44 , Oct 5, 2010 |  BC Extra  |  Company News

AbCheck to discover antibodies in deal with Lilly

AbCheck s.r.o. (Plzen, Czech Republic) will use its three antibody libraries to discover antibodies against targets selected by Eli Lilly and Co. (NYSE:LLY). AbCheck will receive discovery fees and is eligible for milestone payments. Lilly...
08:00 , Jan 25, 2010 |  BC Week In Review  |  Company News

Affimed cancer, antibodies news

Affimed spun out its antibody discovery business into AbCheck s.r.o. AbCheck is located in Plzen, Czech Republic, and Volker Lang, formerly CBO at Affimed, serves as managing director. The spin out will continue Affimed's...